Director
Seres Therapeutics
Cambridge, MA, United States
Elizabeth Halvorsen is the Director of Host Biology in R&D at Seres Therapeutics. Dr. Halvorsen has a PhD in Microbiology from the University of Illinois, followed by postdoctoral research at Harvard Medical School in host-microbe interactions, and an industry postdoctoral fellow at Cubist Pharmaceuticals before joining Seres Therapeutics in 2015.
I do not have any relevant financial / non-financial relationships with any proprietary interests.
Saturday, October 14, 2023
11:30 AM – 11:43 AM US ET